ID
27919
Description
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3); ODM derived from: https://clinicaltrials.gov/show/NCT01121705
Link
https://clinicaltrials.gov/show/NCT01121705
Keywords
Versions (1)
- 12/5/17 12/5/17 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
December 5, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Hepatitis NCT01121705
Eligibility Chronic Hepatitis NCT01121705
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Hypertension, Portal
Data type
boolean
Alias
- UMLS CUI [1]
- C0020541
Description
Kidney Failure
Data type
boolean
Alias
- UMLS CUI [1]
- C0035078
Description
Hepatitis B Surface Antigens | HIV Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0019168
- UMLS CUI [2]
- C0019693
Description
Alcohol consumption U/day
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0001948
- UMLS CUI [1,2]
- C0456683
Description
Intravenous drug use
Data type
boolean
Alias
- UMLS CUI [1]
- C0699778
Description
Systemic disease chronic
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0442893
- UMLS CUI [1,2]
- C0205191
Similar models
Eligibility Chronic Hepatitis NCT01121705
- StudyEvent: Eligibility
C0019196 (UMLS CUI [1,2])
C0019693 (UMLS CUI [2])
C0456683 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,2])